aTyr Pharma Inc.
3545 John Hopkins Road, Suite 250
San Diego
California
92121
United States
258 articles about aTyr Pharma Inc.
-
aTyr Pharma Receives U.S. FDA Orphan Designation For Resolaris
4/27/2015
-
aTyr Pharma Appoints Rare Disease Pioneer Mark Goldberg, M.D., To Board Of Directors
4/27/2015
-
aTyr Pharma Appoints Marcy Graham As Vice President, Investor Relations And Corporate Communications
4/9/2015
-
Rumors Prove True as SoCal's aTyr Pharma Files for $86 Million IPO
4/7/2015
-
aTyr Pharma $76 Million Series E Gets IPO Rumors Flying
4/2/2015
-
aTyr Pharma Secures $76 Million In Series E Financing
4/1/2015
-
aTyr Pharma Inc. Receives European Medicines Agency Orphan Drug Designation For Resolaris In FSHD
2/18/2015
-
aTyr Pharma Inc. Announces First FSHD Patient Study Of Resolaris™
1/28/2015
-
aTyr Pharma Inc. Appoints Fred Ramsdell, Ph.D., As Vice President, Immunology
11/3/2014
-
aTyr Pharma Inc. Appoints John C. McKew, Ph.D., As Vice President, Research
10/22/2014
-
aTyr Pharma Inc., The Hong Kong University Of Science And Technology, The Scripps Research Institute And Stanford University Join In The Discovery Of A New Class Of Human Proteins
7/18/2014
-
aTyr Pharma Inc. Announces Publication Of A Rare Muscle Disease Associated With Regulation Of A Potential Physiocrine
7/15/2014
-
aTyr Pharma Inc. Appoints Biotech Industry Veteran Kathryn Falberg To The Board Of Directors And As Audit Committee Chair
6/4/2014
-
aTyr Pharma Inc. Completes First Phase 1 Study For Rare Disease Program
5/21/2014
-
aTyr Pharma Inc. Appoints David M. Weiner, M.D., As Chief Medical Officer
3/28/2014
-
aTyr Pharma Inc. Appoints Biotech Pioneer, Dr. Ed Penhoet, To Board Of Directors
3/28/2014
-
aTyr Pharma Inc. Appoints Frederic Chereau As President And Chief Operating Officer
2/5/2014
-
aTyr Pharma Inc. Expands Executive Leadership Team to Support Development of New Therapeutics Based on Physiocrine Biology
8/14/2013
-
aTyr Pharma Inc. Awarded Two Patents From USPTO to Support Development of New Therapeutics Based on Physiocrine Biology
8/14/2013
-
aTyr Pharma Inc. Scores $49 Million Financing
7/29/2013